| (210) | Number of the EPO application | 17793075 |
| (220) | Filing date of the EPO application | 2017.05.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 27/2021, 2021.07.07 |
| (110) | EPO patent number | 3452035 |
| (21) | Number of the application | e 2019 0316 |
| (71) | Name(s) of applicant(s), code of the country | MEI Pharma, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | DUNCAN David, US; |
| (73) | Name(s) of owner(s), code of the country | MEI Pharma, Inc., US; |
| (54) | Title of the invention | POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 235/14 (2006.01.01); A61P 35/02 (2006.01.01); A61K 31/4184 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.04.30 |
| (30) | Priority | 201662330673 P, 2016.05.02, US |
| (86) | International application | PCT/US2017/030414, 2017.05.01 |
| (87) | International publication | WO 2017/192451, 2017.11.09 |